Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Kris White and Adolfo García-Sastre.
Kris White
Connection Strength
2.632
Adolfo García-Sastre
  1. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science. 2021 02 26; 371(6532):926-931.
    View in: PubMed
    Score: 0.926
  2. Influenza B virus reverse genetic backbones with improved growth properties in the EB66® cell line as basis for vaccine seed virus generation. Vaccine. 2018 02 21; 36(9):1146-1153.
    View in: PubMed
    Score: 0.753
  3. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling. Proc Natl Acad Sci U S A. 2020 11 10; 117(45):28344-28354.
    View in: PubMed
    Score: 0.227
  4. Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2. Science. 2021 07 30; 373(6554):541-547.
    View in: PubMed
    Score: 0.060
  5. Transcriptomics-based drug repositioning pipeline identifies therapeutic candidates for COVID-19. Sci Rep. 2021 06 10; 11(1):12310.
    View in: PubMed
    Score: 0.059
  6. Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture. Cell Rep. 2021 05 18; 35(7):109133.
    View in: PubMed
    Score: 0.059
  7. TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation. Cell. 2021 05 13; 184(10):2618-2632.e17.
    View in: PubMed
    Score: 0.059
  8. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Front Pharmacol. 2021; 12:633680.
    View in: PubMed
    Score: 0.058
  9. An ultrapotent synthetic nanobody neutralizes SARS-CoV-2 by stabilizing inactive Spike. Science. 2020 12 18; 370(6523):1473-1479.
    View in: PubMed
    Score: 0.057
  10. Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. Science. 2020 12 04; 370(6521).
    View in: PubMed
    Score: 0.057
  11. An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening. Curr Protoc Microbiol. 2020 09; 58(1):e108.
    View in: PubMed
    Score: 0.056
  12. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 10; 586(7827):113-119.
    View in: PubMed
    Score: 0.056
  13. The Global Phosphorylation Landscape of SARS-CoV-2 Infection. Cell. 2020 08 06; 182(3):685-712.e19.
    View in: PubMed
    Score: 0.056
  14. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature. 2020 07; 583(7816):459-468.
    View in: PubMed
    Score: 0.055
  15. Transcription Elongation Can Affect Genome 3D Structure. Cell. 2018 09 06; 174(6):1522-1536.e22.
    View in: PubMed
    Score: 0.049
  16. Influenza virus differentially activates mTORC1 and mTORC2 signaling to maximize late stage replication. PLoS Pathog. 2017 Sep; 13(9):e1006635.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.